|
|
Volumn 6, Issue 12, 2007, Pages 945-
|
|
Novel risk-sharing scheme puts the spotlight on biomarkers
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL MARKER;
BORTEZOMIB;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERYTHROPOIETIN;
M PROTEIN;
SEROTONIN UPTAKE INHIBITOR;
TRASTUZUMAB;
ARTICLE;
COMPENSATION;
COST EFFECTIVENESS ANALYSIS;
DEPRESSION;
DRUG COST;
DRUG INDUSTRY;
DRUG LEGISLATION;
HEALTH CARE SYSTEM;
HEALTH INSURANCE;
HUMAN;
LAW SUIT;
MULTIPLE MYELOMA;
NATIONAL HEALTH SERVICE;
PRIORITY JOURNAL;
REIMBURSEMENT;
RISK MANAGEMENT;
TREATMENT OUTCOME;
|
|
EID: 36749080921
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2478 Document Type: Article |
|
Times cited : (11)
|
|
References (0)
|